Cargando…

Macrophage inhibitory factor 1 acts as a potential biomarker in patients with esophageal squamous cell carcinoma and is a target for antibody-based therapy

Macrophage inhibitory factor 1 (MIC1) is frequently altered in various cancers. The aim of this study was to investigate the clinical significance of MIC1 for esophageal squamous cell carcinoma (ESCC). Serum MIC1 of 286 ESCC and 250 healthy subjects was detected, the diagnostic performance was asses...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Xiao-Bing, Jiang, Xing-Ran, Yu, Xi-Ying, Wang, Lin, He, Shun, Feng, Fei-Yue, Guo, Li-Ping, Jiang, Wei, Lu, Shih-Hsin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2014
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4317821/ https://www.ncbi.nlm.nih.gov/pubmed/24383865 http://dx.doi.org/10.1111/cas.12331

Ejemplares similares

Inhibitory Role of Pentraxin-3 in Esophageal Squamous Cell Carcinoma
por: Ma, Dan, et al.
Publicado: (2016)

Prognostic CpG Methylation Biomarkers Identified by Methylation Array in Esophageal Squamous Cell Carcinoma Patients
por: Kuo, I-Ying, et al.
Publicado: (2014)

Macrophage migration inhibitory factor: a potential driver and biomarker for head and neck squamous cell carcinoma
por: Wang, Sha-sha, et al.
Publicado: (2016)

Hypoxic Tumor-Derived Exosomal Circ0048117 Facilitates M2 Macrophage Polarization Acting as miR-140 Sponge in Esophageal Squamous Cell Carcinoma
por: Lu, Qijue, et al.
Publicado: (2020)

Characterization of Esophageal Microbiota in Patients With Esophagitis and Esophageal Squamous Cell Carcinoma
por: Jiang, Zongdan, et al.
Publicado: (2021)

Macrophage migration inhibitory factor: A promising oncogenic serological biomarker for oral squamous cell carcinoma
por: Zepeda-Nuño, José Sergio, et al.
Publicado: (2021)

Three‐dimensional conformal radiation therapy alone for esophageal squamous cell carcinoma: 10‐year survival outcomes
por: Fan, Xing‐Wen, et al.
Publicado: (2019)

Identification and characterization of stem cells in mammalian esophageal stratified squamous epithelia
por: Yang, Yanan, et al.
Publicado: (2022)

Thrombin acts as inducer of proinflammatory macrophage migration inhibitory factor in astrocytes following rat spinal cord injury
por: Yang, Ting, et al.
Publicado: (2022)

Biomarkers of apoptosis and survival in esophageal squamous cell carcinoma
por: Takikita, Mikiko, et al.
Publicado: (2009)

Long-Acting HIV-1 Fusion Inhibitory Peptides and their Mechanisms of Action
por: Wang, Chen, et al.
Publicado: (2019)

Spatial transcriptomics analysis of esophageal squamous precancerous lesions and their progression to esophageal cancer
por: Liu, Xuejiao, et al.
Publicado: (2023)

Identification of a DNA Methylome Profile of Esophageal Squamous Cell Carcinoma and Potential Plasma Epigenetic Biomarkers for Early Diagnosis
por: Li, Xufeng, et al.
Publicado: (2014)

Proteomics Reveal the Inhibitory Mechanism of Levodopa Against Esophageal Squamous Cell Carcinoma
por: Li, Zhenzhen, et al.
Publicado: (2020)

Novel mechanism of immune evasion mediated by tumor‐associated macrophages in esophageal squamous cell carcinoma
por: Diao, Fei‐Yu
Publicado: (2020)

The Role of DBR1 as a Candidate Prognosis Biomarker in Esophageal Squamous Cell Carcinoma
por: Xu, Xiaoqin, et al.
Publicado: (2022)

Upregulation of Centromere Proteins as Potential Biomarkers for Esophageal Squamous Cell Carcinoma Diagnosis and Prognosis
por: Wang, Xiao, et al.
Publicado: (2022)

Evaluation of Serum Exosomal lncRNAs as Diagnostic and Prognostic Biomarkers for Esophageal Squamous Cell Carcinoma
por: Yan, Suzhen, et al.
Publicado: (2020)

Machine Learning and Novel Biomarkers Associated with Immune Infiltration for the Diagnosis of Esophageal Squamous Cell Carcinoma
por: Zhang, Jipeng, et al.
Publicado: (2022)

S100A7 as a potential diagnostic and prognostic biomarker of esophageal squamous cell carcinoma promotes M2 macrophage infiltration and angiogenesis
por: Lu, Zhiliang, et al.
Publicado: (2021)

CD163 as a marker of M2 macrophage, contribute to predict aggressiveness and prognosis of Kazakh esophageal squamous cell carcinoma
por: Hu, Jian Ming, et al.
Publicado: (2017)

Expression and phosphorylation of stathmin correlate with cell migration in esophageal squamous cell carcinoma
por: LIU, FEI, et al.
Publicado: (2013)

cis-Acting Elements and trans-Acting Factors in the Transcriptional Regulation of Raf Kinase Inhibitory Protein Expression
por: Zhang, Boyan, et al.
Publicado: (2013)

Characterization of the Oral and Esophageal Microbiota in Esophageal Precancerous Lesions and Squamous Cell Carcinoma
por: Li, Zhengqi, et al.
Publicado: (2021)

Clinical values of Ku80 upregulation in superficial esophageal squamous cell carcinoma
por: Wang, Shuai, et al.
Publicado: (2018)

Predicting response to immunotherapy plus chemotherapy in patients with esophageal squamous cell carcinoma using non-invasive Radiomic biomarkers
por: Zhu, Ying, et al.
Publicado: (2021)

The level of macrophage migration inhibitory factor is negatively correlated with the efficacy of PD-1 blockade immunotherapy combined with chemotherapy as a neoadjuvant therapy for esophageal squamous cell carcinoma
por: Wu, Liangliang, et al.
Publicado: (2023)

Inducing multiple antibodies to treat squamous cell esophageal carcinoma
por: Hoshino, Isamu, et al.
Publicado: (2020)

Serum HOTAIR as a novel diagnostic biomarker for esophageal squamous cell carcinoma
por: Wang, Wenjian, et al.
Publicado: (2017)

Peripheral blood cell count ratios are predictive biomarkers of clinical response and prognosis for non‐surgical esophageal squamous cell carcinoma patients treated with radiotherapy
por: Zhi, Xiaohui, et al.
Publicado: (2020)

Weighted Correlation Network Analysis of Cancer Stem Cell-Related Prognostic Biomarkers in Esophageal Squamous Cell Carcinoma
por: Zhao, Mengnan, et al.
Publicado: (2022)

Prognostic impact of body mass index stratified by smoking status in patients with esophageal squamous cell carcinoma
por: Sun, Peng, et al.
Publicado: (2016)

Autoantibodies as Potential Biomarkers for the Early Detection of Esophageal Squamous Cell Carcinoma
por: Xu, Yi-Wei, et al.
Publicado: (2014)

Serum Macrophage Migration Inhibitory Factor as a Biomarker of Active Pulmonary Tuberculosis
por: Shang, Zhong-bo, et al.
Publicado: (2018)

Inhibitory Effects of Rabdosia rubescens in Esophageal Squamous Cell Carcinoma: Network Pharmacology and Experimental Validation
por: Lin, Ruoyang, et al.
Publicado: (2022)

Inhibitory Effects of (−)-Epigallocatechin-3-gallate on Esophageal Cancer
por: Wang, Liu-Xiang, et al.
Publicado: (2019)

DUSP6, a tumor suppressor, is involved in differentiation and apoptosis in esophageal squamous cell carcinoma
por: MA, JIANJUAN, et al.
Publicado: (2013)

The roles of macrophage migration inhibitory factor in retinal diseases
por: Zhang, Hongbing, et al.
Publicado: (2023)

Esophageal mycobiome landscape and interkingdom interactions in esophageal squamous cell carcinoma
por: Rao, Wen-Qing, et al.
Publicado: (2023)

Serum Metabolomics for Biomarker Screening of Esophageal Squamous Cell Carcinoma and Esophageal Squamous Dysplasia Using Gas Chromatography-Mass Spectrometry
por: Zhang, Su, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_kfvkr44nidd23qd19nc42e1i6a